HC Wainwright & Co. Initiates Coverage On PaxMedica With Buy Rating, Announces Price Target of $3
BenzingaDec 4, 2023 19:45
PaxMedica Analyst Ratings
BenzingaDec 4, 2023 19:44
Buy Rating on PaxMedica: Strategic Value of Suramin and PRV in Neurological Disorder Treatments
TipRanksDec 4, 2023 19:19
No Data
No Data